Kategorien
Aktien

Opko Health 3,73 USD +4,77% 

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Nasdaq
Börse Nasdaq
ISIN US68375N1037
  • OPKO Health Inc
    Börse Nasdaq
    ISIN US68375N1037 WKN: A0MUUJ
    Symbol OPK
  • Opko Health Inc.
    Börse Börse Berlin
    Symbol XCY
    EUR
  • Opko Health Inc.
    Börse Börse Stuttgart
    Symbol XCY
    EUR
  • OPKO HEALTH INC
    Börse Gettex System der Börse München
    Symbol XCY
    EUR
  • OPKO HEALTH INC
    Börse Börse Düsseldorf
    Symbol XCY
    EUR
  • OPKO HEALTH INC
    Börse Quotrix System der Börse Düsseldorf
    Symbol XCY
    EUR
  • OPKO HEALTH INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol XCY
    EUR
  • Opko Health Inc.
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US68375N1037
    MXN
  • Symbol XCY
    EUR
  • Opko Health Inc.
    Börse TLV
    ILA
  • Symbol XCY
  • MXN
  • Opko Health
    Börse London Stock Exchange
ISIN US68375N1037
WKN A0MUUJ
Symbol OPK
Börse Nasdaq Zeitzone: America/Mexico_City
Mitarbeiter 4.196

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 3,73 USD +4,77% 

52 News & Informationen zur Opko Health Aktie

  • The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
    markets.businessinsider.com

    The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

    Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…

  • Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario.
    globenewswire.com

    Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario.

    The growing Type 2 Diabetes prevalence has increased the demand for effective drug therapies. There are different classes of emerging drugs administered…

  • OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
    globenewswire.com

    OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

    MIAMI, July 20, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended June…

  • Hedge Funds Are Buying Helmerich & Payne, Inc. (HP)
    insidermonkey.com

    Hedge Funds Are Buying Helmerich & Payne, Inc. (HP)

    The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their…

  • Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
    fool.com

    Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week

    The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.

  • OPKO Health (OPK) Inks Licensing Deal for AntagoNAT Technology
    zacks.com

    OPKO Health (OPK) Inks Licensing Deal for AntagoNAT Technology

    OPKO Health's (OPK) latest licensing agreement is expected to advance the development and commercialization of potential disease-modifying therapeutics, especially for Dravet syndrome.

  • OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
    globenewswire.com

    OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

    MIAMI, July 12, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced it has entered into an exclusive worldwide agreement with…

  • Israel stocks higher at close of trade; TA 35 up 0.54% By Investing.com
    investing.com

    Israel stocks higher at close of trade; TA 35 up 0.54% By Investing.com

    Israel stocks higher at close of trade; TA 35 up 0.54%

  • Esoteric Testing Market by Type, Technology, End-user and Region - Global Forecast to 2026
    prnewswire.com

    Esoteric Testing Market by Type, Technology, End-user and Region – Global Forecast to 2026

    /PRNewswire/ — The “Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS,…

  • Global Clinical Laboratory Market Report 2021-2026 - Competitive Developments, Strategies, Mergers And Acquisitions And New Product...
    thestreet.com

    Global Clinical Laboratory Market Report 2021-2026 – Competitive Developments, Strategies, Mergers And Acquisitions And New Product Developments

    DUBLIN, July 6, 2021 /PRNewswire/ — The “Global Clinical Laboratory Market – Analysis By Test, End User, By Region, By Country (2021 Edition): Market Insights

  • Global Genetic Testing Market (2020 to 2026) - Featuring Abbott Laboratories, 23andMe & Cepheid Among Others
    prnewswire.com

    Global Genetic Testing Market (2020 to 2026) – Featuring Abbott Laboratories, 23andMe & Cepheid Among Others

    /PRNewswire/ — The

  • Global Genetic Testing Market (2020 To 2026) - Featuring Abbott Laboratories, 23andMe & Cepheid Among Others
    thestreet.com

    Global Genetic Testing Market (2020 To 2026) – Featuring Abbott Laboratories, 23andMe & Cepheid Among Others

    DUBLIN, July 2, 2021 /PRNewswire/ — The

  • 8 Hot Penny Stocks That You Should Add to Your July Watchlist
    pennystocks.com

  • 9 Top Penny Stocks to Watch That Shot Up Big Today
    pennystocks.com

  • Israel stocks lower at close of trade; TA 35 down 0.13% By Investing.com
    investing.com

    Israel stocks lower at close of trade; TA 35 down 0.13% By Investing.com

    Israel stocks lower at close of trade; TA 35 down 0.13%

  • OPKO Health (OPK) and Nicoya Sign RAYALDEE Deal
    zacks.com

    OPKO Health (OPK) and Nicoya Sign RAYALDEE Deal

    OPKO Health's (OPK) subsidiary EirGen Pharma to develop and commercialize RAYALDEE in Greater China in collaboration with an affiliate of Nicoya Therapeutics.

  • Israel stocks higher at close of trade; TA 35 up 0.06% By Investing.com
    investing.com

    Israel stocks higher at close of trade; TA 35 up 0.06% By Investing.com

    Israel stocks higher at close of trade; TA 35 up 0.06%

  • Global Digital Dose Inhalers Market To Reach $4.9 Billion By 2026
    thestreet.com

    Global Digital Dose Inhalers Market To Reach $4.9 Billion By 2026

    SAN FRANCISCO, June 25, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • OPKO Health : Asset Purchase Agreement (Form 8-K)
    marketscreener.com

    OPKO Health : Asset Purchase Agreement (Form 8-K)

    Entry into a Material Definitive Agreement.

    On June 16, 2021,… | June 24, 2021

  • Israel stocks lower at close of trade; TA 35 down 0.14% By Investing.com
    investing.com

    Israel stocks lower at close of trade; TA 35 down 0.14% By Investing.com

    Israel stocks lower at close of trade; TA 35 down 0.14%

  • Supplements seller that markets anti-aging pill is ‘pure hype,’ short seller claims
    nypost.com

    Supplements seller that markets anti-aging pill is ‘pure hype,’ short seller claims

    ChromaDex, a Los Angeles-based marketer that says it's

  • Top 10 Biotech Penny Stocks to Watch in July 2021
    pennystocks.com

  • Israel stocks higher at close of trade; TA 35 up 0.27% By Investing.com
    investing.com

    Israel stocks higher at close of trade; TA 35 up 0.27% By Investing.com

    Israel stocks higher at close of trade; TA 35 up 0.27%

  • OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
    globenewswire.com

    OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

    MIAMI, June 22, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Katherine Stueland as President and Chief…

  • OPKO Health : BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry
    marketscreener.com

    OPKO Health : BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry

    MIAMI, June 22, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company , today announced a COVID-19 testing program for U.S. based crew and guests who cruise with… | June 22, 2021

  • Greenberg Traurig Boosts Miami Office International Capabilities with Two Attorneys
    prweb.com

    Greenberg Traurig Boosts Miami Office International Capabilities with Two Attorneys

    Miami, FL (PRWEB) June 22, 2021 — Global law firm Greenberg Traurig, P.A., is bolstering its international Litigation and Tax Practices with the addition of

  • OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics
    marketscreener.com

    OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

    MIAMI, June 21, 2021 — OPKO Health, Inc. today announced that its subsidiary EirGen Pharma has entered into an agreement with Nicoya Macau Limited, an affiliate of Nicoya Therapeutics ,… | June 21, 2021

  • OPKO Health (OPK) Inks Agreement to Sell Its Ireland Facility
    zacks.com

    OPKO Health (OPK) Inks Agreement to Sell Its Ireland Facility

    OPKO Health (OPK) expects to improve its business efficacy and focus on oral solid dose products post the sale of its Ireland facility.

  • Israel stocks higher at close of trade; TA 35 up 0.65% By Investing.com
    investing.com

    Israel stocks higher at close of trade; TA 35 up 0.65% By Investing.com

    Israel stocks higher at close of trade; TA 35 up 0.65%

  • Game Plan: Cramer's 'Mad Money' Recap (Friday 1/15/21)
    thestreet.com

    Game Plan: Cramer's 'Mad Money' Recap (Friday 1/15/21)

    Jim Cramer looks at what to watch for as earnings season kicks into gear next week.

  • Opko Health expects to beat its guidance for PCR tests for Covid in 4Q (NASDAQ:OPK)
    seekingalpha.com

  • OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)
    seekingalpha.com

    OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

  • OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access
    markets.businessinsider.com

    OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access

    ELMWOOD PARK, N.J., Jan. 13, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced Scarlet H…

  • 3 Penny Stocks For Your January 2021 Watch List If You Like Biotech
    pennystocks.com

  • Global Oncology Precision Medicine Market (2020 to 2030) - Analysis and Forecast
    benzinga.com

    Global Oncology Precision Medicine Market (2020 to 2030) – Analysis and Forecast

    Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) — The “Global Oncology Precision Medicine Market: Focus on Application Area, Ecosystem Type, Country Data (15 …

  • OPKO Health's BioReference Laboratories Reports Results Of The Largest COVID-19 Public School Testing Program Nationwide
    thestreet.com

    OPKO Health’s BioReference Laboratories Reports Results Of The Largest COVID-19 Public School Testing Program Nationwide

    ELMWOOD PARK, N.J., Jan. 4, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19

  • OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide
    prnewswire.com

    OPKO Health’s BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide

    /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public…

  • Best Penny Stocks To Buy Right Now? 4 Biotech Stocks To Watch
    pennystocks.com

  • Pfizer, OPKO: FDA To Review BLA For Somatrogon To Treat Patients With Growth Hormone Deficiency
    markets.businessinsider.com

    Pfizer, OPKO: FDA To Review BLA For Somatrogon To Treat Patients With Growth Hormone Deficiency

    (RTTNews) – Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced FDA has accepted for filing the initial Biologics License Application for somat…

  • Weekly CEO Buys Highlight
    gurufocus.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Aktie: Opko Health

Das Unternehmen Opko Health aus USA beschäftigt 4.196 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Pharma tätig.

Opko Health ist nur in 6 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares Ageing Population  UCITS  ETF gewichtet Opko Health mit 0,21% im ETF.

6 ETFs die in Opko Health investieren

Dir gefallen die Informationen zu Opko Health?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Opko Health?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Opko Health?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Opko Health?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect